Genor Biopharma Holdings Ltd. Announces Date for Extraordinary General Meeting
I'm PortAI, I can summarize articles.
Genor Biopharma Holdings Ltd. will hold an extraordinary general meeting on December 22, 2025, in Shanghai. Shareholders will consider resolutions including authorizing a director to execute documents related to the Whitewash Waiver and changing the company's English and Chinese names upon merger. The original content was published by Genor Biopharma via the Hong Kong Stock Exchange's Issuer Information Service.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments